1 To whom correspondence should be addressed. Telephone: 011-6172438. Fax: 91-11-616-5886. E-mail: kdatta@jnuniv.ernet.in. tifunctional nature of HABPl has been elucidated by in vitro interaction of HABPl with HIV-1 Rev, suggesting that; this protein may be a cellular cofactor promoting HIV-1 Rev function (1). Here we report the localization of the HABPl locus on human chromosome 17p12-p13.
Metaphase chromosome spreads were prepared from phytohemagglutinin-stimulated human lymphocytes synchronized with BrdU (18 mg/ml) according to standard procedures. A 1.1-kb eDNA probe ofHABPl was biotinylated with dATP using a BRL Bio-Nick labeling kit (5). Fluorescence in situ hybridization (FISH) was performed using this probe and was detected with FITC conjugated to avidin according to the procedure described previously (5,6). Mter the hybridization with the labeled probe and stringent washing, slides were counterstained with DAPI for 5 min and then mounted in 90% glycerol in 20 mM Tris-HCl (pH 8.0), 2.3% DAPCO antifade (Sigma), and propidium iodide (0.05-0.ljLg/ml, Sigma). In the data presented here, fluorescence signals were found on sister chromatids of both homologues of chromosome 17 ( Fig. lA) with 63% efficiency, wbich mea~s that 63 of 100 metaphases were positive, having at least two signals on both chromatids of the chromosome. DAPI staining of same metaphase spreads is presented in Fig~ lB. There was no additional locus picked up by FISH detection; thus DAPI banding indicated that the specific signals were located at human chromosome 17, region pl2-p13.
To determine the mapped closely flanking markers, we searched the STS markers of human chromosome 17 published from Whitehead Institute (7), and it revealed that the 3' UTR of the gene encoding HABPl has 99.5% similarity, from base 928 to base 1163, with STS Wl-9242, whose re- The role of hyaluronan binding protein 1 (HABPI) in cell signaling was investigated and in vitro kinase assay demonstrated that it is a substrate for MAP kinase. Phosphorylation of endogenous HABPI was also observed following treatment of J774 cells with PMA. HABPI was coimmunoprecipitated with activated ERK, confirming their physical interaction in the cellular context. Upon PMA stimulation of normal rat fibroblast (Fill) and transformed (HeLa) cells, the HABPI level in the cytoplasm gradually decreased with a parallel increase in the nucleus. In HeLa cells, within 6 h of PMA treatment, HABPI was completely translocated to the nucleus, which was prevented by PD98059, a selective inhibitor of ERK. We also observed that the nuclear translocation ofHABPl is concurrent with that of ERK, suggesting that ERK activation is a requirement for the translocation of HABPI. It is thus established for the first time that HABPl is a substrate for ERK and an integral part of the MAP kinase cascade. © 2002 Elsevier Science (USA) Key Words: MAP kinase; hyaluronic acid binding protein 1 (HABPl); gClqR/p32.
Hyaluronic acid (HA), a ubiquitously expressed complex polysaccharide, is implicated in diverse cellular processes such as cell proliferation (1), locomotion, differentiation (2), and tumorigenesis (3). This multifaceted regulatory effect ofHA is likely to be mediated via its interaction with proteins that bind to it. In support, a family of proteins known as "hyaladherins" containing a defined HA binding motif (4) were identified. We have purified and characterized a novel member of this family, viz. HABP1; which specifically binds to HA with a dissociation constant of 10-9 M (5). Subse-quently, we have identified the gene encoding this protein from human fibroblast (6), recognized as HABPl by HUGO. We have further reported that HABP1 i~ localized on human chromosome 17p12-p13 (7) and iE also present as a pseudogene on chromosome 21 (8).
HABP1 is a cell adhesive protein that is highly phosphorylated at threonine residues in transformed fibroblasts and is presumably involved in cell transformation (9, 10). Further, enhanced phosphorylation oJ HABP1 by HA, PMA, and calyculin was also demonstrated, suggesting its role in cellular signaling (11). Sequence analysis of HABP1 revealed five phosphory· lation sites for CKII and one for extracellular signa: regulated kinase (6), thus raising the possibility tha1 it is a MAP kinase substrate. Extracellular signa: regulated kinases (ERKs), members of the mitogen activated protein kinase (MAP kinase) family, are activated by signals from receptor tyrosine kinases, cytokine receptors, and seven membrane-spanning heterotrimeric G protein-coupled receptors (12) (13) (14) . Sequence analysis (6, 15) also reveals that the sequence of HABP1 is identical to p32, a protein copurified with alternate mRNA splicing factor, SF2 (16) and the receptor of gC1q, the complement component (17). Though a mitochondrial localization signal is present only in the precursor form of HABP1, its locations in other subcellular compartments have also been documented. Others and we have reported that the mature form of HABP1/gC1qR is localized on the surface oJ normal fibroblasts (9, 18) and lymphoblastoma cells (19) . There are also evidences that HABP1 can be localized in the nucleus where it interacts with several nuclear proteins. Nuclear localization of HABP1 has also been reported in cells infected with HIV-type 1 (20-23), adenovirus (24), 26) and rubella virus (27) . In cells infected with Rubella Virus, HABP1 is trapped by the viral protein and transported to the nucleus in a Ca 2 + -dependent manner (27) (28), factor XII, vitronectin (29), and lamin B Receptor (30, 31) have also been reported. Therefore, data accumulated over the decade indicate that HABP1/p32/gClqR is localized in multiple cellular compartments and interacts with disparate types of proteins presumably leading to divergent biological consequences. Thus, in order to investigate the biochemical basis of different subcellular localization of HABPl, we report that HABPl is a bonafide substrate for ERKl and upon mitogenic stimulation, both ERKl and HABPl are simultaneously translocated to the nucleus. Therefore, this report for the first time establishes a direct link between nuclear localization of HABPl and the MAP kinase pathway.
MATERIALS AND METHODS
Cell culture, metabolic labeling, and PMA stimulation. F111 fibroblast, HeLa, J774 and Raji cells were routinely cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum, penicillin (100 1-Lg/ml), streptomycin (100 1-Lg/ml), and fungizone (50 1-Lg/ml) at 37°C in a humidified 5% C0 2 environment. PD98059 (50 ~-tMl, reported as inhibitor of MEK1 (32) and cysteamine (400 ~-tMl, having anti-oxidative and antiproliferative activity inhibiting MAP kinase pathway (33), were added to the culture media and 90 min later the cells were stimulated with PMA (100 ng/ml). Similarly for nonradioactive stimulation, cells were starved for 12-16 h in serum-free medium; refed with fresh serum free medium and then either PMA (40 nM) or PD98059 (50 ~-tMl or both was added. Cells were then incubated for various time periods and processed for immunofluorescence or for immunoblotting.
Immunokinase assay for HABPl phosphorylation. Serum starved J774 cells were stimulated with PMA (100 ng/ml), Ca 2 + ionophore (250 ng/ml) or HA (20 ~-tg/ml) for 30 min. Afterwards the cells were lysed in RIPA buffer. The cleared lysates containing equal amounts of proteins were incubated with anti-ERK1 (C-16, Santa Cruz Biotechnologies, 1:100) antibody for 1 hat 4°C and then with protein A Sepharose beads for 1 hat 4oC with constant shaking. The antigenantibody complexes were washed 5 times with RIPA buffer and twice with kinase buffer (25 mM Tris-Cl, pH 7.0, 10 mM MgCl 2 , 0.25 mM Na 3 V0 4 , 1 mM DTT). Immunocomplexes were then resuspended in kinase buffer with recombinant HABP1 (rHABP1) and [y- 32 P]ATP and the reaction was carried out at 30oC for 30 min. The samples were resolved on 12.5% SDS-polyacrylamide gel and then autoradiographed.
In vitro kinase assay using recombinant MAP kinase. In vitro kinase assay was carried out using commercially available activated MAP kinase (Stratagene) and HABP1 (purified according to Ref. 6) at 30°C for 30 min as per the supplier's protocol where [ 32 P]ATP was used as a source of phosphate. The reaction was stopped by addition recombinant HABP1 under appropriate conditions (see Materials and Methods for details). Lanes 7 and 8, increasing concentrations (1 and 2 ~-tgl of recombinant HABP1 was allowed to react with 0.02 1-Lg of activated recombinant MAP kinase. Lane 3 is a positive control where myelin basic protein was phosphorylated by activated MAP kinase, lane 1 and 2 are showing negative controls. (C) Coimmunoprecipitation ofERK1/ERK2 using HABPI antibody. Following PMA treatment, Raji cells were lysed and the lysates were immunoprecipitated using anti-HABPI antibody and the precipitated proteins were tested by immunoblotting with anti-ERK1/ERK2 antibody. 32 P] orthophosphates and treated with PMA, PD98059 and cysteamine. Lysates were analyzed for HABP1 phosphorylation by immunoprecipitation with anti-HABP1 antibody followed by autoradiography of 12.5% SDS-PAGE (A). Band C show the immunodetection of activated ERK by anti phospho-ERK antibody and the total level ofERK by anti ERK antibody respectively under different conditions. MAP kinase inhibitor cysteamine and ERK specific inhibitor PD98059 were used for inhibiting MAP kinase activity.
of Laemmli's sample buffer. The samples were resolved on 12.5% SDS-polyacrylamide gel and phosphorylation ofHABP1 was visualized by autoradiography.
Immunoprecipitation of HABPl. Sub-confluent cells were rendered quiescent by incubation with serum depleted medium for 12 h followed by incubation with serum deprived phosphate free Dulbecco's minimal essential medium for 2 h and then labeled with 250 f.LCi of [
32 P] orthophosphate. Mter treatment with PMA, PD98059 and cysteamine cells were washed once with ice-cold PBS followed by lysis in RIPA buffer. Clarified lysates were incubated first with polyclonal antibody against recombinant HABP1 for 1 hat 4oC and then with 25 f.Ll of protein A-Sepharose beads for 1 h with rotation at 4°C. The immune complex was washed with RIPA buffer for 8 times, resolved on 12.5% SDS-polyacrylamide gel and then autoradiographed. For co-immunoprecipitation ofHABP1 and ERK, following stimulation given by PMA, cells were lysed in RIPA buffer and HABP1 was immunoprecipitated as described. Finally the immune complexes were extracted by boiling in Laemmli buffer and resolved on 12.5% SDS-PAGE. The proteins were electrotransferred to nitrocellulose membrane and subjected to immunoblot analysis with anti-phospho p44/p42 MAP kinase antibody (1:500, New England Biolabs Inc.).
Preparation of cell extracts. Trypsinized cells were washed once in PBS (0.01 M, pH 7.2), suspended in 20 mM Hepes, pH 8.0; 20% glycerol; 1.5 mM MgC1 2 ; 10 mM NaCl; 0.2 mM EDTA; 0.1% Triton X-100 and 0.02 mM PMSF and incubated on ice for 30 min with occasional shaking. The suspension was then centrifuged at 2500 rpm for 15 min at 4°C. The supematant containing the cytosolic fraction was collected and the pellet containing the nuclear fraction was resuspended in 20 mM Hepes, pH 8.0; 20% glycerol; 1.5 mM MgC1 2; 10 mM NaCl; 0.2 mM EDTA; 0.1% SDS, and 0.02 mM PMSF. The resuspended nuclear fraction was incubated at room temperature for 15 min, vortexed vigorously for 1 min, and centrifuged at 14,000 rpm for 10 min at 4°C. The supernatant was collected and the pellet was discarded.
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Immunodetection. Lysates, obtained from PMA stimulated cells were separated on 12.5% SDS-PAGE and transblotted on nitrocellulose membrane. Proteins were immunodetected either by anti HABP1 antibody, anti-ERK antibody (1:2000, Santa Cruz) or antiphospho p44/p42 MAP kinase antibody (1:500, New Englabs Biolabs Inc.) and then visualized by nitroblue tetrazolium/5-bromo-4-chloro-3 indolyl phosphate detection system or by enhanced chemiluminescence (Amersham) using either goat anti-rabbit alkaline phosphatase conjugate (1:5000) or goat anti-mouse alkaline phosphatase conjugate (1:7500, Santa Cruz), respectively.
Confocal laser-scanning microscopy. Cells were cultured on coverslips and treated with PMA as described in metabolic labeling. Cells were then washed once with PBS and fixed with chilled methanol. After blocking with 3% BSA for 1 h at 37oC, the cells were incubated simultaneously with polyclonal anti-ERK antibody (1:100, Santa Cruz Biotechnologies) and monoclonal anti-HABP1 (1:50) antibody followed by incubation with FITC conjugated anti-rabbit antibody (1:250, Santa Cruz Biotechnologies) and Texas-red conjugated anti-mouse antibody (1:250, Santa Cruz). Stained cells were analyzed under confocal microscope.
RESULTS

HABP 1 as a MAP Kinase Substrate
Sequence analysis reveals one ERK phosphorylation site e 60 PELTSTP 166 ) in HABPl, we thus examined whether HABPl is a substrate for ERK. Recombinant HABPl was used in an in vitro kinase assay using either immunoprecipitated endogenously activated ERK1/ERK2 or commercially available activated MAP kinase as enzyme source. Transformed macrophage cell line J77 4 was treated with PMA, Ca 2 + ionophore or HA; activated ERK1/ERK2 was immunoprecipitated with anti-ERK1/ERK2 antibody from the cell lysate and was used in the immunokinase assay. As shown in Endogenously activated ERK1/ERK2 also effectively phosphorylated rHABPl (lanes 5-7). As it is known, besides PMA, which is a potent activator of MAP kinase, Ca 2 + ionophore (34) and HA (35) .. 
